CrowdStrike's proactive response to the crisis suggests robust short-to-medium-term growth. Read why CRWD stock may work ...

Other expected highfliers include KKR, AMD, Microsoft and Live Nation Investors are always hoping that companies will surprise analysts by showing higher profits than expected. These "earnings beats" ...

GraniteShares is expanding its suite of leveraged ETFs with three new products tracking technology companies, according to a ...

As of 11:30 a.m. ET, indexes are mostly in the green today. Let's take a peek at their performance: Dow Jones Industrial ...

On Monday, Oppenheimer maintained its Outperform rating and $450.00 stock price target on NASDAQ:CRWD, despite removing CrowdStrike Holdings (NASDAQ:CRWD) from its top picks for ...

Joseph M. Terranova loves anything related to cybersecurity. Jim Lebenthal names Amazon.com as his final trade. On Nov. 7, ...

In the last week, the United States market has stayed flat, but it is up 33% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying high growth tech stocks ...

India's Grasim Industries reported a lower second-quarter adjusted profit on Thursday, dragged down by poor demand in its ...

Palo Alto Networks has made a bold shift to accelerate platformization. Read why it may hurt short term but has excellent ...

Shares initiated a two year, 87% decline in value, accelerated by the bear market of 2022. Now, with positive revenue and ...

Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. The drugmaker reported a consolidated profit of 3.54 ...

Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...